Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA5 | P11021 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 5/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.37 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | MPO | P05164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14917402 | 1.00 | HSPA5 (0.43) | HSPA5TSHRCYP2D6HIF1ATAAR1 | |
| SCHEMBL14917394 | 0.94 | HSPA5 (0.48) | HSPA5TSHRCYP2D6HIF1ATAAR1 | |
| SCHEMBL14917396 | 0.94 | HSPA5 (0.48) | HSPA5TSHRCYP2D6HIF1ATAAR1 | |
| SCHEMBL14916883 | 0.93 | HSPA5 (0.43) | HSPA5TSHRCYP2D6HIF1ATAAR1 | |
| SCHEMBL6594440 | 0.76 | HSPA5 (0.54) | HSPA5TSHRCYP2D6HIF1ATAAR1 | |
| SCHEMBL31110321 | 0.72 | CA12 (0.66) | HSPA5CA12CA2CA9KDM4E | |
| SCHEMBL27341308 | 0.72 | CA12 (0.66) | HSPA5CA12CA2CA9KDM4E | |
| SCHEMBL18651816 | 0.72 | CA12 (0.66) | HSPA5CA12CA2CA9KDM4E | |
| SCHEMBL6413423 | 0.72 | SMN1; SMN2 (0.49) | HSPA5TSHRCYP2D6HIF1ATAAR1 | |
| SCHEMBL6413419 | 0.72 | SMN1; SMN2 (0.49) | HSPA5TSHRCYP2D6HIF1ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9061982-B2 | Process for the preparation of oxovinylionol and its O-protected derivatives | BASF SE (DE) | 2015-06-23 | — | — | US | disclosed |
| US-20130116473-A1 | PROCESS FOR THE PREPARATION OF OXOVINYLIONOL AND ITS O-PROTECTED DERIVATIVES | BASF SE (DE) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116473-A1 | PROCESS FOR THE PREPARATION OF OXOVINYLIONOL AND ITS O-PROTECTED DERIVATIVES | HAO2, VAT1, SOD3 | HSPA5 2386/4885TSHR 1640/4885CYP2D6 729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.